Showing results (241-250 of 387) with videos related to
Sort By:
Pageof 39
American Heart Journal|July 3, 2023
Transthyretin amyloid cardiomyopathy among patients hospitalized for heart failure and performance of an adapted wild-type ATTR-CM machine learning model: Findings from GWTG-HFAnthony E Peters, Nicole Solomon, Karen Chiswell, et al.European Journal of Heart Failure|March 15, 2022
Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registryNeil Keshvani, Anurag Mehta, Heather M Alger, et al.Journal of Cardiac Failure|November 18, 2021
Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF RegistryStephen J Greene, Javed Butler, Anne S Hellkamp, et al.Journal of Cardiac Failure|January 24, 2025
Implantable Cardioverter-Defibrillators and Cardiovascular Resynchronization Therapy with Left Ventricular Assist DevicesA MOMENTUM 3 Trial AnalysisGabriel Sayer, Mustafa M Ahmed, Mandeep R Mehra, et al.American Heart Journal|January 26, 2021
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbiditiesNancy M Albert, Rachel J Tyson, C Larry Hill, et al.Journal of the American Heart Association|June 20, 2022
Angiotensin Receptor Neprilysin Inhibition and Associated Outcomes by Race and Ethnicity in Patients With Heart Failure With Reduced Ejection Fraction: Data From CHAMP-HFBrittany Chapman, Anne S Hellkamp, Laine E Thomas, et al.American Heart Journal|August 10, 2016
Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE)Adam D DeVore, Melissa A Greiner, Puza P Sharma, et al.Proceedings of the National Academy of Sciences of the United States of America|January 31, 2009
Tbx2b is required for ultraviolet photoreceptor cell specification during zebrafish retinal developmentKaren Alvarez-Delfin, Ann C Morris, Corey D Snelson, et al.The Canadian Journal of Cardiology|June 25, 2019
Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF TrialStephen J Greene, G Michael Felker, Anna Giczewska, et al.The American Journal of Cardiology|January 22, 2022
Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device SupportHimabindu Vidula, Onur Altintas, Scott McNitt, et al.Pageof 39